Conclusion: The results that no patient in our study experienced worsening conditions or severe study drug adverse reactions could suggest that a short-term therapy of low-dose corticosteroid combined with oral factor Xa inhibitor at the early stage of COVID-19 infections could prevent the progressing to critical disease.